| Quantity | 20 nmol, 50 nmol, 100 nmol, 200 nmol | 5 slides | 100 μg | 1mg | 20 nmol, 50 nmol, 100 nmol, 200 nmol |
| Description | The product SIRGT30761WQ is a type of small interfering RNA (siRNA) that targets IRF9 gene and regulates the expression of gene. The siRNA interferes with the expression of IRF9 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. It has The product SIRGT30761WQ is a type of small interfering RNA (siRNA) that targets IRF9 gene and regulates the expression of gene. The siRNA interferes with the expression of IRF9 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. It has potential applications in RNA interference (RNAi) and gene therapy development.... Read More | Creative Biolabs' Neuropathy Frozen Tissue Panels are designed for the study of Alzheimer's disease, Parkinson's disease, dementia, multiple sclerosis, progressive supranuclear palsy (PSP) and depression. | This product GTTS-WK14445MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & Pseudo-UTP. It ecodes the AK124399 protein. This product can be used in CD1C-CD141- dendritic cell-related researches. | This product is a Human DBH membrane protein expressed in vitro E.coli expression system. The protein is for research use only and is not approved for use in humans or in clinical diagnosis. | The product SIRGT51321WQ-2OMe is a type of small interfering RNA (siRNA) that targets SYT8 gene and regulates the expression of gene. The siRNA interferes with the expression of SYT8 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNAThe product SIRGT51321WQ-2OMe is a type of small interfering RNA (siRNA) that targets SYT8 gene and regulates the expression of gene. The siRNA interferes with the expression of SYT8 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2_-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.... Read More |